Enceladus Pharmaceuticals BV

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Holding

Employees: -

Market Cap: -

Website: http://enceladus.nl

Clinical Trials

A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma

Phase 1

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Dexamethasone

First Posted Date: 2017-01-26

Last Posted Date: 2020-11-06

Lead Sponsor: Enceladus Pharmaceuticals BV

Target Recruit Count: 7

Registration Number: NCT03033316

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy